AI heart scanner aims to catch silent AFib before it strikes

NCT ID NCT07173673

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence-enhanced ECG (SmartECG-AFrisk) can detect atrial fibrillation (AF) earlier than usual care in 1,230 adults with symptoms like palpitations or dizziness but no prior AF diagnosis. Participants are randomly assigned to either standard monitoring or AI-guided care, where the algorithm flags high-risk individuals for closer monitoring. The goal is to see if AI can improve AF detection within six months and help prevent serious events like stroke.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Artificial intelligence-enhanced electrocardiography (SmartECG-AFrisk) device
What this could lead to
If successful, this could provide a simple, non-invasive way to catch hidden atrial fibrillation earlier, potentially preventing strokes and other complications.
What could go wrong
This is an early-stage trial with no results yet. The AI may not improve detection rates significantly, and findings may not apply outside the study population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Yonsei University College of Medicine

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.